$4.43
-0.06-1.34%
At close: -
$4.42
-0.01000-0.23%
After Hours: Feb 21, 4:00 PM EDT
Vanda Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Vanda Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-13 | $-0.08 | $-0.14 | 42.9 % |
Q3 | 2024-11-06 | $-0.09 | $-0.16 | 43.8 % |
Q2 | 2024-07-31 | $-0.08 | $-0.21 | 61.9 % |
Q1 | 2024-05-08 | $-0.07 | $0.05 | -240.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-13 | $53.19M | $51.00M | 4.28 % |
Q3 | 2024-11-06 | $47.65M | $49.15M | -3.05 % |
Q2 | 2024-07-31 | $50.47M | $47.86M | 5.46 % |
Q1 | 2024-05-08 | $47.46M | $48.50M | -2.14 % |
Vanda Pharmaceuticals (VNDA) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on February 13, 2025 for Q4.
The Actual EPS was $-0.08, which beat the estimate of $-0.14.
The Actual Revenue was $53.2M, which beat the estimate of $51M.
Browse earnings estimates, EPS, and revenue on all stocks.